Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from MCK

Is McKesson Stock Outperforming the Dow?

As McKesson has outperformed the Dow Jones over the past year, analysts are bullish about the stock’s prospects.

Barchart

These 3 Stocks Are Generating Massive Returns on Capital

Take a gander at these three stocks that are generating returns on invested capital (ROIC) that are among the best in the U.S. large-cap stock universe.

MarketBeat

McKesson Stock: Analyst Estimates & Ratings

McKesson has underperformed relative to the S&P 500 Index over the past year, but Wall Street analysts remain bullish on its growth prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Healthcare IT Stocks Revolutionizing Patient Care

With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, and companies driving this shift are poised for significant upside. Therefore, investors might find opportunities in fundamentally strong healthcare IT stocks like Medtronic (MDT), McKesson Corp. (MCK), and Embecta (EMBC). Read more….

StockNews.com

Earnings Preview: What To Expect From McKesson's Report

McKesson is expected to announce its third-quarter results next month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Barchart

Is Cencora Stock Underperforming the S&P 500?

Cencora has trailed the S&P 500 index over the past year, but analysts remain highly bullish about the stock’s prospects.

Barchart

Is McKesson Stock Underperforming the Nasdaq?

Although McKesson has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Do Wall Street Analysts Like McKesson Stock?

McKesson has exceeded the broader market's performance over the past year, and Wall Street analysts are highly positive about the stock's outlook.

Barchart

3 Undervalued Health-Tech Stocks to Buy for Long-Term Growth

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical areas, as well as the demand for personalized medicine. Thus, it could be wise to invest in fundamentally solid health-tech stocks McKesson (MCK), Cardinal Health (CAH), and Zimmer Biomet (ZBH) poised for long-term…

StockNews.com

McKesson's Quarterly Earnings Preview: What You Need to Know

With McKesson gearing up to release its second-quarter earnings next month, analysts expect a double-digit surge in earnings.

Barchart

Is Cardinal Health Stock Underperforming the Nasdaq?

Despite Cardinal Health’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is McKesson Stock Underperforming the S&P 500?

McKesson has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

How Is Cencora's Stock Performance Compared to Other Healthcare Stocks?

Cencora has outperformed other healthcare stocks over the past year and analysts remain bullish about the stock’s prospects.

Barchart

McKesson Stock Outlook: Is Wall Street Bullish or Bearish?

McKesson has outperformed the broader market this year, and Wall Street analysts are optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

S&P Futures Climb as Risk Sentiment Improves, Disney Earnings on Tap

September S&P 500 E-Mini futures (ESU24) are trending up +0.91% this morning, extending the rebound from Monday’s dramatic selloff, supported by remarks from a senior Bank of Japan official ruling out further rate hikes during periods of market instability, while investors awaited a new batch of earnings reports.

Barchart

McKesson's Q2 2024 Earnings: What to Expect

With McKesson gearing up to release its first-quarter earnings next month, analysts project a single-digit earnings dip.

StockNews.com

With 25% YTD Gains, Is McKesson a Smart Investment Now?

McKesson (MCK) reported consistent revenue growth and solid profit margins in the last reported quarter, supported by robust demand for pharmaceuticals and medical supplies and efficient cost management. With nearly 25% year-to-date gains, should you invest in this healthcare stock? Read on to learn more….

Barchart

2 'Strong-Buy' Rated Growth Stocks to Scoop Up Now

There are good reasons to invest in the long-term potential of these growth stocks.

Get all your
news in one place.

100's of premium titles.
One news app.

inkl

The iGaming consolidated in Canada after Ontario's model was found consistent with the Criminal Code by the Ontario Superior Court

While changes to the iGaming market in Ontario were being heralded as a success by the province and commercial gambling operators alike, there has been a battle going on in the background.

Barchart

Chart of the Day: McKesson - Hitting New Highs

Author's Note: Sometimes a stock will come up continually on my screeners. MCK was featured 10/16/2023 when it was trading at $462.56. The stock has gained 30%+ since then. The Chart of the Day belongs to the healthcare medical distribution company McKesson (MCK) . I found the stock by using...

Barchart

How Is McKesson's Stock Performance Compared to Other Healthcare Stocks?

McKesson has outperformed other healthcare stocks over the past three months, and analysts remain optimistic about the stock’s prospects.

Barchart

Stock Index Futures Muted Ahead of More Fed Speak, Disney Earnings on Tap

June S&P 500 E-Mini futures (ESM24) are up +0.09%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.02% this morning after three major U.S. benchmark indices ended the regular session higher as recent U.S. jobs data and remarks from Federal Reserve officials buoyed rate-cut hopes while investors awaited further…

StockNews.com

Why Investors Are Flocking to These 2 Medical Stocks

Given the growing demand for healthcare facilities, rapid integration of digital technology, and transformative biotechnology breakthroughs, the medical industry is poised for continued growth and profitability this year and beyond. Amid this, let’s find out why investors are flocking to medical stocks Vertex Pharmaceuticals (VRTX) and McKesson (MCK). Read more….

StockNews.com

3 Medical Stocks Smart Investors Want

The medical industry, pivotal in elevating the quality of human life, is poised to remain buoyed due to medical breakthroughs, advanced medical discoveries, and rising health consciousness among individuals. Given this backdrop, quality medical stocks McKesson Corporation (MCK), Qiagen N.V. (QGEN), and DaVita Inc. (DVA) could be solid portfolio additions…

Barchart

3 Healthcare Stocks Ready to Soar in 2024

Unlock the gates of wellness with these breakout healthcare stocks.

1 2 3 4 5

People

Xi Jinping

6,689 stories

Mangeet Kaur BounsMangeet

595 stories

Thomas Barkin

53 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.